Innovation is never easy. It requires the audacity to create a new path, one where we will encounter novel obstacles that demand both resourcefulness and bold imagination. But when we stand together, ...
After dealing with a deployment problem with glucose monitors earlier this year, interim CEO Jake Leach said improving ...
The warning follows inspections of three Philips facilities that found failures to meet standards for reporting complaints ...
The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more clinical trials.
National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained ...
Medline named multi-year preferred supplier deals, international expansion and takeovers as ways it will drive further growth ...
Measuring financial returns from AI can be challenging, experts said at the HLTH conference last week. But other metrics, ...
The medtech firm is using Nvidia’s technology in its Monarch robotic platform for urology.
Trials from Edwards, Philips and Penumbra were among the most-watched studies at the annual cardiovascular meeting.
Patients treated with Symplicity Spyral had significantly lower blood pressure than people who received a sham treatment ...
Strong sales growth in the company’s electrophysiology unit comes amid a market fight between some of the medtech industry’s ...
Integrating a controlled-release iodine layer into hip implants could reduce the rate of potentially fatal infections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results